NCT01603264 A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01) Status COMPLETED Phase PHASE1
NCT01602874 Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia Status WITHDRAWN Phase PHASE3
NCT01602341 Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01601834 A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340 Status COMPLETED Phase PHASE1
NCT01601821 Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids Status COMPLETED Phase PHASE4
NCT01599806 Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Status COMPLETED Phase PHASE3
NCT01599754 Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients Status TERMINATED Phase PHASE3
NCT01599377 Tofacitinib Bioequivalence Study Comparing Tablets And Capsules Status COMPLETED Phase PHASE1
NCT01598324 Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder Status TERMINATED Phase N/A
NCT01597895 Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01597258 Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01597193 Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer Status COMPLETED Phase PHASE1
NCT01595867 Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo Status COMPLETED Phase PHASE1
NCT01595438 Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Status COMPLETED Phase PHASE3
NCT01592240 Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin Status COMPLETED Phase PHASE2
NCT01591421 P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. Status COMPLETED Phase PHASE1/PHASE2
NCT01589614 A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804 Status COMPLETED Phase PHASE1